-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, H5hNVnall8qdRn6aHw5pw8FbSA6x6r24rtLRASGlSBcO3DcGQ6MsEsTRy9CL6SgK RlxjsOS8J819Zgue0CN3ZA== 0000898432-08-000839.txt : 20080818 0000898432-08-000839.hdr.sgml : 20080818 20080818172704 ACCESSION NUMBER: 0000898432-08-000839 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20080818 DATE AS OF CHANGE: 20080818 GROUP MEMBERS: ANDREEFF EQUITY ADVISORS, L.L.C. GROUP MEMBERS: MAPLE LEAF CAPITAL I, L.L.C. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ardea Biosciences, Inc./DE CENTRAL INDEX KEY: 0001103390 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943200380 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-59411 FILM NUMBER: 081025813 BUSINESS ADDRESS: STREET 1: 4939 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 760-602-8422 MAIL ADDRESS: STREET 1: 4939 DIRECTORS PLACE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: INTRABIOTICS PHARMACEUTICALS INC /DE DATE OF NAME CHANGE: 20000127 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ANDREEFF DANE CENTRAL INDEX KEY: 0001201810 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: C/O ANDREEFF EQUITY ADVISORS LLC STREET 2: 450 LAUREL STREET STE 2105 CITY: BATON ROUGE STATE: LA ZIP: 70801 BUSINESS PHONE: 2253447780 MAIL ADDRESS: STREET 1: C/O ANDREEFF EQUITY ADVISORS LLC STREET 2: 450 LAUREL ST STE 2105 CITY: BATON ROUGE STATE: LA ZIP: 70801 SC 13G/A 1 sc13g-a_ardeabios.txt SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b),(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No. 2) Ardea Biosciences, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 03969P107 - -------------------------------------------------------------------------------- (CUSIP Number) June 12, 2008 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [_] Rule 13d-1(b) [X] Rule 13d-1(c) [_] Rule 13d-1(d) - ---------- The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, SEE the NOTES). CUSIP No. 03969P107 --------------------- 1. NAME OF REPORTING PERSONS Dane Andreeff 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Canada NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 1,227,279 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 1,227,279 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,227,279 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 9.6% 12. TYPE OF REPORTING PERSON IN, HC ________________________________________________________________________________ CUSIP No. 03969P107 --------------------- 1. NAME OF REPORTING PERSONS Andreeff Equity Advisors, L.L.C. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 1,227,279 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 1,227,279 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,227,279 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 9.6% 12. TYPE OF REPORTING PERSON IA, PN ________________________________________________________________________________ CUSIP No. 03969P107 --------------------- 1. NAME OF REPORTING PERSONS Maple Leaf Capital I, L.L.C. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [_] (b) [X] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5. SOLE VOTING POWER 0 6. SHARED VOTING POWER 676,975 7. SOLE DISPOSITIVE POWER 0 8. SHARED DISPOSITIVE POWER 676,975 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 676,975 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [_] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.1% 12. TYPE OF REPORTING PERSON PN, HC ________________________________________________________________________________ CUSIP No. 03969P107 --------------------- Item 1(a). Name of Issuer: Ardea Biosciences, Inc. ____________________________________________________________________ Item 1(b). Address of Issuer's Principal Executive Offices: 2131 Palomar Airport Road, Suite 300 Carlsbad, CA 92011 ____________________________________________________________________ Item 2(a). Name of Persons Filing: Dane Andreeff Andreeff Equity Advisors, L.L.C. Maple Leaf Capital I, L.L.C. ____________________________________________________________________ Item 2(b). Address of Principal Business Office, or if None, Residence: 140 East St. Lucia Lane Santa Rosa Beach, FL 32459 ____________________________________________________________________ Item 2(c). Citizenship: Dane Andreeff - Canada Andreeff Equity Advisors, L.L.C. -- Delaware Maple Leaf Capital I, L.L.C. -- Delaware ____________________________________________________________________ Item 2(d). Title of Class of Securities: Common Stock ____________________________________________________________________ Item 2(e). CUSIP Number: 03969P107 ____________________________________________________________________ Item 3. If this statement is filed pursuant to rule 13d-1(b), or 13d-2(b) or (c) check whether the person filing is: One of the following Not applicable. _______________________________________________________________________ Item 4. Ownership. The information in items 1 and 5 through 11 on the cover pages (pp. 2-6) to this Schedule 13G is hereby incorporated by reference. _______________________________________________________________________ Item 5. Ownership of Five Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following []. _______________________________________________________________________ Item 6. Ownership of More Than Five Percent on Behalf of Another Person. If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than five percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. _______________________________________________________________________ Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. If a parent holding company or Control person has filed this schedule, pursuant to Rule 13d-1(b)(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company or control person has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Mr. Andreeff is the Managing Member of Andreeff Equity Advisors, L.L.C. ("AEA") and Maple Leaf Capital I, L.L.C. ("Capital"). AEA is the Investment Adviser and Capital is the General Partner of the following limited partnerships, each of which owns less than 5% of the issuer's securities: (i) Maple Leaf Partners, L.P. (ii) Maple Leaf Partners I, L.P. AEA is the Investment Adviser and Mr. Andreeff is the Director of Maple Leaf Offshore, Ltd., which owns less than 5% of the issuer's securities. _______________________________________________________________________ Item 8. Identification and Classification of Members of the Group. If a group has filed this schedule pursuant to Section 240.13d-1(b)(1)(ii) (J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Section 240.13d-1(c) or Section 240.13d-1(d), attach an exhibit stating the identity of each member of the group. _______________________________________________________________________ Item 9. Notice of Dissolution of Group. Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. ______________________________________________________________________ Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. August 18, 2008 ---------------------------------------- (Date) /s/ Dane Andreeff ----------------------------- Dane Andreeff * ANDREEFF EQUITY ADVISORS, L.L.C.* By: Dane Andreeff /s/ Dane Andreeff ----------------------------- Name: Dane Andreeff Title: Managing Member MAPLE LEAF CAPITAL I, L.L.C.* By: Dane Andreeff /s/ Dane Andreeff ------------------------------ Name: Dane Andreeff Title: Managing Member *The Reporting Persons disclaim beneficial ownership in the shares reported herein except to the extent of their pecuniary interest therein. Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties for whom copies are to be sent. Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). EX-99 2 exh99.txt EXHIBIT A --------- In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of each of them of a statement on Schedule 13G and all amendments thereto with respect to the Common Stock of Ardea Biosciences, Inc. beneficially owned by each of them, and the inclusion of this Joint Filing Agreement as an exhibit thereto. Dated: August 18, 2008 /s/ Dane Andreeff ----------------------------- Dane Andreeff ANDREEFF EQUITY ADVISORS, L.L.C. By: Dane Andreeff /s/ Dane Andreeff ----------------------------- Name: Dane Andreeff Title: Managing Member MAPLE LEAF CAPITAL I, L.L.C. By: Dane Andreeff /s/ Dane Andreeff ------------------------------ Name: Dane Andreeff Title: Managing Member -----END PRIVACY-ENHANCED MESSAGE-----